DWM
ABBV icon

DecisionMap Wealth Management’s AbbVie ABBV Stock Holding History

DecisionMap Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
1,170
+10
+0.9% +$2.15K 0.16% 115
2026
Q1 		$252K Sell
1,160
-166
-13% -$36.8K 0.16% 114
2025
Q4 		$303K Buy
1,326
+40
+3% +$9.11K 0.19% 101
2025
Q3 		$298K Buy
1,286
+147
+13% +$29.9K 0.19% 96
2025
Q2 		$211K Sell
1,139
-61
-5% -$11.3K 0.15% 120
2025
Q1 		$251K Buy
+1,200
New +$233K 0.19% 105

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

DecisionMap Wealth Management's ABBV Position: Q2 2026 in Review

DecisionMap Wealth Management increased its AbbVie (ABBV) stake by 0.86% in Q2 2026, buying an estimated $2.15K and bringing the position to 1,170 shares worth $294K. The position accounts for 0.16% of the portfolio, ranked #115.

DecisionMap Wealth Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $303K in Q4 2025. 1,010 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • DecisionMap Wealth Management held 1,170 shares of AbbVie worth $294K as of Q2 2026.
  • DecisionMap Wealth Management bought 10 AbbVie shares in Q2 2026, an estimated $2.15K.
  • AbbVie made up 0.16% of DecisionMap Wealth Management's portfolio in Q2 2026, its #115 holding.
  • DecisionMap Wealth Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • DecisionMap Wealth Management's AbbVie position peaked at $303K in Q4 2025.
  • 1,010 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on DecisionMap Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.